Commercial Credit Report for Bangkok Genomics Innovation PCL

CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals. Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue. We also offer solutions that can help ease private company financial risk assessment. Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively.

A partial report preview for Bangkok Genomics Innovation PCL is shown below. Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database. To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

	Bangkok Genomics Innovation PCL
Klongtoey, 3689 Rama 4 Phrakanong,
	BANGKOK, 10110 Thailand	Ticker: BKGIBKGI

Business Summary

Bangkok Genomics Innovation Public Company Limited is a Thailand-based company that operates laboratories and provides medical analysis services. The Company provides reproductive health screening services, including screening for fetal chromosomal abnormalities from maternal blood using the NIFTY brand using Next-Generation Sequencing (NGS) technology combined with other technology to screen for chromosomal abnormalities in babies such as down syndrome to reduce the risk of miscarriage from unnecessary amniocentesis. Its other screening tests include COLOTECT Colon Cancer Screening and DNALL Personal DNA Testing. Its technology services include DNA base sequencing, RNA base sequencing and metabolism and protein omics. It also contributes to the provision of various research services, both medical and other aspects. Its customers include government customers, such as medical schools, health centers, as well as private sector customers, such as clinics, hospitals and others.

(Source: 10-K405)

Scores and Ratings

FRISK^® Score	Z'' Score	PAYCE^® Score	DBT Index	Moody's Rating	Fitch Rating	DBRS Rating
Yes	Yes	-	-	-	-	-

Financials, News and Filings

Latest Statement	Last Audit	News	SEC Filings	Bankruptcy Filings	Suit & Judgment Filings	Tax Lien Filings
12/31/2023	12/31/2023	Yes	-	-	-	-

Industries

SIC Code	Description
8734	Testing laboratories
8093	Specialty outpatient facilities, not elsewhere classified

General Information

Outstanding Shares:	160,000,000	(As of 12/31/2023)
Stock Exchange:	BAK

SITE MAP | ABOUT US | DIRECTORY | STOCK QUOTE: CRMZ | SIGN IN